Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 48Observational 3Expanded_access 1

Sponsor

Cancer Type

Plasma cell 4Lymphoid 3Other hematologic neoplasm 1

Conditions

Lymphoma 2Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1

Interventions

Rituximab 29Surveys and Questionnaires 25Blood Specimen Collection 17Gene Expression Profiling 15Flow Cytometry 14Polymerase Chain Reaction 13Amplified Fragment Length Polymorphism Analysis 13Microarray Analysis 11Observation 10Interviews as Topic 10Psychiatric Rehabilitation 9Lenalidomide 9Immunohistochemistry 9Cytogenetic Analysis 9obinutuzumab 8Watchful Waiting 8Therapeutics 8ibrutinib 7Drug Therapy 7Cyclophosphamide 7Bendamustine Hydrochloride 7Vincristine 6Prednisone 6Magnetic Resonance Spectroscopy 6fludarabine 5In Situ Hybridization, Fluorescence 5Immunologic Techniques 5Data Collection 5Brentuximab Vedotin 5Biopsy 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × plerixafor × Lymphoid × Clear all
NCT01738373 2015-03-23

Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation

Sanofi

Completed
262 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT00741325 2014-02-11

Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).

Sanofi

Completed
178 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT01700608 2012-10-04

Prospective Observational Study on Plerixafor After Chemotherapy

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Completed
27 enrolled
LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡